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Background: An increased number of emergency visits at the end of life may indicate poor-quality cancer care.
The study aimed to investigate the prevalence and utilization of emergency visits and to explore the reasons for
emergency department (ED) visits among cancer patients at the end of life.
Methods: A retrospective cohort study was performed by tracking one year of ambulatory medical service records
before death. Data were collected from the cancer dataset of Taiwan’s National Health Insurance Research Database
(NHIRD).
Results: A total of 32,772 (19.2%) patients with malignant cancer visited EDs, and 23,883 patients died during the
study period. Of these, the prevalence of emergency visits in the mortality group was 81.5%, and their ED utilization
was significantly increased monthly to the end of life. The most frequent types of cancer were digestive and peritoneum
cancers (34.8%), followed by breast cancer (17.7%) and head and neck cancers (13.3%). Older patients, males, and those
diagnosed with metastases, respiratory or digestive cancer were more likely to use ED services at the end of life. Use of an
ED service in the nearest community hospital to replace medical centers for dying cancer patients would be
more acceptable in emergency situations.
Conclusions: Our study provided population-based evidence related to ED utilization. An understanding of the
reasons for such visits could be useful in preventing overuse of ED visits to improve the quality of end-of-life care.
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Cancer is the first leading cause of death in Taiwan and
worldwide. 8.2 million people died from cancer in 2012,
and the number of new annual cases will continue to in-
crease by about 70% over the next 2 decades [1]. In the
aging Taiwan society, there is also an increasing number of
individuals dying of cancer who are covered by the national
health insurance (NHI) system. Approximately 29,000
Taiwanese people died from cancer in 1997, and this in-
creased to 40,300 in 2007, which accounted for 13 percent
of deaths attributable to cancer [2,3]. There is a growing ap-
preciation of cancer patients’ needs for end-of-life (EOL)
care services, especially for those with terminal illnesses.
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unless otherwise stated.the increasing anticancer therapies, ICU stays, and hospital
deaths [4,5]. Patients were found to be more likely to re-
ceive aggressive care if they were younger or lived in rural
regions with fewer medical resources [6-8]. However, this
might go against old Taiwanese beliefs. In Taiwan, “Dying
in his/her own home is a good death” when it comes to the
most important issue for terminal patients and their fam-
ilies in Taiwanese culture [9]. To respect the end of life
medical wishes of patients, the Taiwan Hospice-Palliative
Care Act was initiated in 2000. Its purpose was to help in-
curable patients to relieve their physical, psychological and
spiritual suffering by palliative or supportive medical care,
and it permits the legal termination of end-of-life patients’
life-supporting devices based on safeguarding the rights
and wills of these patients [10]. Whereas the NHI in Taiwan
issues reimbursement to cancer patients who have the rightis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nomic burden of cancer treatment in intensive care units
presents an increasing trend [11].
For dying cancer patients, aggressive medical treatments
and emergency department (ED) visits can result in distress
and exhaustion. Abdominal pain, lung cancer, and dyspnea
were reported to be the most common reasons for ED visits
during the final six months of life and the final two weeks
of life in Canada [12]. However, the available information is
insufficient due to previous studies focusing on the experi-
ences of these patients who visit an ED near the end of life
being limited and having small sample sizes. Taiwan na-
tional claims data linked to the death registry database have
been used in a similar field, but consideration of the aggres-
sive treatment in EDs during the end of life and related fac-
tors were the focus of this study, which was to the best of
our knowledge the first of its kind. The quality of EOL care
received by terminal cancer patients and the affected factors
have also seldom been explored in Asian countries [13].
Requesting an intensive ED service at the EOL stage will
not improve the quality of EOL or prolong a patient’s life,
and also goes against the traditional beliefs regarding a
good death in Taiwan. Therefore, the causes, symptoms
and unavoidable events that lead to a terminal cancer pa-
tient visiting the emergency department deserve more at-
tention. Reduction of futile aggressive medical treatment
needs to be emphasized in order to improve the quality of
EOL care [14,15]. To our knowledge, little is known about
nationwide ED visits by terminal cancer patients when they
are near the end of life [16]. Using Taiwan national claims
data linked to the death registry database could be inform-
ative. In order to respond to current and emerging health
issues apidly and effectively, the Taiwan National Health
Insurance Bureau (NHIB) established a uniform system
to control the quality of medical services and the cod-
ing database. The coverage of this single-payer program
is greater than 99%. This nationwide research database
contains cancer registration and original claims data for
reimbursement, enabling analysis by researchers. The
study aimed to explore the prevalence and ED utiliza-
tions of all cancer patients in Taiwan in order to reveal
the associations between cancer terminal patients and
increased utilization of emergency visits near the end-of-life
and to compare the distributions of diagnostic problems at
EDs between cancer survivors and decedents.
Methods
Data source, security, and quality control
Taiwan launched a single-payer National Health Insur-
ance (NHI) Program, financed jointly by payroll taxes,
subsidies, and individual premiums, in 1995, and its
coverage rate expanded to approximately 99% of the 23
million people in Taiwan who were enrolled in the NHI
Research Database. All enrollees enjoy almost freeaccess to healthcare, with a small co-payment by most
clinics and hospitals [17,18]. The NHI Research Data-
base includes nationwide population-based data with
good quality control and representation and is provided
to scientists in Taiwan for research purposes [14,19].
The information related to all subjects is encrypted
using a double scrambling protocol for research pur-
poses to protect the privacy of patients. Theoretically,
it is impossible to query the data alone to identify indi-
viduals at any level using this database. All researchers
who wish to use the NHIRD are required to sign a writ-
ten agreement declaring that they have no intention of
attempting to obtain information that could potentially
violate the privacy of patients or care providers.
The study design was a retrospective cohort study. The
protocol was evaluated by the NHRI (Application Number:
101020), who gave their agreement to the planned analysis
of the NHIRD. The data protection and permission proto-
cols were also approved by the Institutional Review Board
(IRB) of Taoyuan General Hospital, which has been certifi-
cated by the Department of Health, Taiwan (IRB Approval
Number: TYGH100021).Inclusion and exclusion criteria of the study population
and definition
In order to focus on ED utilization among end-of-life ma-
lignant cancer patients, the following criteria were identi-
fied: (1) emergency cases were excluded if they had used
the services of emergency departments but their insurance
numbers were not valid for tracing. (2) Patients with malig-
nant cancer were diagnosed according to the International
Classification of Diseases, Ninth Revision, Clinical Modifi-
cation (ICD-9-CM), with first three-digit codes ranging
from 140 to 208. The diagnosis codes of cancer types were
grouped into six major categories. Their ICD-9-CM codes
were defined as described in Table 1. (3) To find the death
dates of subjects, another registered catastrophic illness
dataset was linked to identify the survival status of the
target population and perform the analyses [17]. (4) ED
utilization of those with a diagnosis of cancer was identified
from the NHIRD, confirmed by the case type code [20].
The definition of end-of-life is: “Any patient who has
contracted a serious illness, diagnosed by a physician as at
an incurable stage, and dying within 6 months, whose ill-
ness will inevitably lead to death in the near future”. The
study variable “urban and rural” was defined according to
the degree of rurality, which was calculated by the Taiwan
NIH research institute by employing parameters used in
rurality analysis, which include population density (less
than the mean per km2), the proportion%) of elderly resi-
dents in the whole population, and proportion of actual
workers in the area population [21]. The severity of each
ED visiting was presented by triage scale.
Table 1 Characteristics of cancer patients in Taiwan, 2008 (n = 170,271)
All pat. (n = 170,271) ED visitors (n = 32,772) Mortality of ED visitors (n =23,883)
Age, yr,
Mean (S.D.) 61.0 (14.9) 64.0 (21.5) 67.0 (14.4)
Gender, No. (%)
Male 84215 (49.5) 20037 23.8 15551 18.5
Female 86056 (50.5) 12735 14.8 8332 9.7
Types of cancer (ICD_9 codes)
Head and neck (140-149,160,161) 22600 4088 18.1 2819 12.5
Digestive and peritoneum (150-159) 59223 15568 26.3 12245 20.7
Colorectal (153-154) 33008 11371 34.5 9628 29.2
Other GI (150-152, 155-159) 27483 4722 17.2 3032 11.0
Respiratory organs (162-165) 16520 6523 39.5 5667 34.3
Lung cancer(162) 13152 5820 44.3 5192 39.5
Other (163-165,190,192-194) 2294 578 25.2 428 18.7
Bone, connective tissue, skin and breast (170-175) 35697 3134 8.8 1674 4.7
Melanoma/sarcoma (170-172) 3314 670 20.2 515 15.5
Breast (174) 30118 2315 7.7 1052 3.5
Genitourinary organs (179-189) 39475 5125 13.0 3050 7.7
Ovary (183) 3737 519 13.9 335 9.0
Prostate (185) 9782 1328 13.6 835 8.5
Metastases (196-199) 10086 4837 48.0 4215 41.8
Lymphoma/leukemia (200-208) 9403 2114 22.5 1334 14.2
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from all insured beneficiaries to select the study sub-
jects from Jan 1 2008 to Dec 31 2008. We investigated
the ED utilizations of all cancer survivors and dece-
dents. A total of 177,721 patients with a cancer diagno-
sis were identified, 35,477 cancer patients who died in
2008 and 142,244 survivors who were alive in 2008.
125,905 cancer survivors and 11,594 cancer decedents
who died in 2008 without making an ED visit in the
one-year observation period were excluded. For com-
parison without a lead time bias, 7,450 subjects in the
survival group were also excluded as their survival sta-
tus was missing or they did not survive or were not
identified in the cancer dataset at Dec 31 2008. Thus,
170,271 patients with a cancer diagnosis were eligible
and the ED visitors numbered 32,772. Among the ED
visitors, the surviving cases totalled only 8,889. The
other 23,883 cancer patients who died in 2008 were
retrospective to investigate the whole one year records
before they died. The flowchart of this study is shown
in Figure 1.Figure 1 Flow diagram of this study.Statistical analysis
Descriptive statistics are represented as numbers of
cases, percentages, and means with standard deviation(SD). Categorical data were analyzed using the Chi-
square test. The Mantel-Haenszel Chi-square test was
used to test for trends. The independent t-test and 95%
confidence intervals (95% CIs) were used to analyze the
significant differences in ED utilization between the
two subgroups. All analyses of data were conducted
using Microsoft SQL Server 2012 (Microsoft Corpor-
ation) and statistical calculations were performed using
the Statistical Package for Social Sciences for Windows
(SPSS 22.0).
Table 2 Utilization of emergency medical services among






ED-visiting subjects 23883 8889
Age, mean (S.D.) 67.0 (14.4) 59.5 (14.7) <0.001
Gender, n (%)
Female 8332 (34.9) 4403 (49.5) <0.001





8980 (37.6) 3138 (35.5) <0.001
Medical centers or
local hos.
14903 (62.4) 5701 (64.5)
ED hospitals with
hospice, n (%) ward
No 9332 (39.1) 3366 (38.1) 0.052
Yes 14551 (60.9) 5473 (61.9)
Location of hospital,
n (%)
Rural 3624 (15.2) 1071 (12.1) <0.001
Urban 20259 (84.8) 7768 (87.9)
Prevalence of ED
visit (95% CI)
67.25 (66.8-67.8) 6.60 (6.5-6.7) <0.001
Admission after the
ED visitsa, n (%)
1160 (4.9) 210 (2.4) <0.001
Distributions of ED
visits triagesb
Level I, count(%) 5647 (11.3) 575 (4.3) <0.001
Level II, count(%) 23521 (47.0) 5508 (41.3)
Level III, count(%) 19444 (38.9) 6892 (51.7)
Level IV, count(%) 1387 (2.8) 366 (2.7)
aMean of those admission days were shown in text; Medical Cost, averaged
number of ED visiting times, and prevalence of ED visit were shown in
the text.
bExcluding missing data, the distributions of traditional ED triaged were
presented because a new 5-level triage scale had been proceed in Taiwan
after 2010.
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Characteristics of the cancer population
The characteristics of the cancer patients and emer-
gency cases that had used emergency department (ED)
services before death are described in Table 1. A total of
170,271 patients with malignant cancer were identified,
of whom 84,215 were male and 86,056 were female. Of
those, the eligibility criteria identified 32,772 (19.2%)
patients who had utilized an ED and 23,883 (14.0%)
who died during the study period. The most frequent
types of cancer in 2008 were digestive and peritoneum
cancers (34.8%), followed by breast cancer (17.7%) and
cancers of the head and neck (13.3%). However, the
most common medical problems leading to an ED visit
were found to be metastases (ICD-9 codes 196-199),
lung cancer (code 162), and digestive and peritoneum
cancers (codes 150-159). The top three mortality rates
of cancer patients who visited an ED within 6 months of
the end of life were those with metastases (41.8%), lung
cancer (39.5%) and colorectal cancer (29.2%). Table 1
also shows the age and gender distributions of the en-
rolled subjects. Approximately 20% of the cancer pa-
tients made an ED visit in a year, the majority being
male patients (23.8%), older patients, and those near the
end of life. The mean age of the mortality group was
67.0 (±14.4) years, and was significantly greater than
that of the survival group (p < 0.001).
The characteristics of the cancer patients in 2008 are
listed in Table 2, stratified by survival status. 35,477
(20.8%) cancer patients who died during the study
period were classified into the mortality group; the other
134,794 (79.2%) survivors were alive in 2008 and were
classified into the survival group. Among the mortality
group, 23,883 dying patients used the majority of the ED
resources, with 58,791 ED visits (81.5%), and the mean
number of visits was 2.46 per person (95% confidence
interval, CI: 2.43 to 2.49) in the last six months of life.
The prevalence of ED utilization was 67.3% (95% CI:
66.8% to 67.8%) before death, which was significantly
higher than that of the survival group (with a prevalence
of 6.6%, 95% CI: 6.5% to 6.7%). Among the survival
group, the average number of ED visits was 1.51 per per-
son (95% CI: 1.47 to 1.55) within the 6-month observa-
tional period, which was significantly lower than that of
the mortality group (p < 0.001).
The patients in the mortality group who had used ED
services had a more severe triage (p < 0.001), and higher
admission rate (4.9% vs 2.4% compared to the other group,
p < 0.001) that could lead to subsequent aggressive inter-
ventions and more treatment-related expenditure and
greater length of stay in their last 6 months of life. Their
total medical expenditure was significantly higher than the
expenditure for the surviving cancer patients during the
same observational period (US$7,442.4 vs. US$4,243.6,p < 0.001). In average, the length of stay 3.61 days
(±3.47) was estimated for the mortality group, which
was significantly more than the length of stay for the
survival group (mean length of stay: 2.91 ± 1.47). Each
kind of medical expenditure in emergency care, includ-
ing diagnosis, treatment, drug costs and partial pay-
ment by themselves, each facet was observed in the
mortality group approximately 1.4 to 2-fold higher than
in the survival group (p < 0.001).
Dying patients could make ED visits for the relief of
symptoms in the nearest community hospital rather than
medical centers under emergency conditions. The odds ra-
tio of the use of community hospitals for ED visits was sig-
nificant at 1.10 (95% CI: 1.04-1.15) in the mortality group
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CI: 1.21-1.40) was also correlated with the ED utilization in
emergency conditions, but hospitals with a hospice ward
were not significantly related (OR = 1.04, 95% CI: 0.99-1.10)
among the cancer population.
Comparisons of diagnostic categories of ED visits
between cancer survivors and cancer decedents
ED visits for cancer-related problems were identified
from the cancer dataset of the National Health Insur-
ance Research Database (NHIRD). Of 211,054 ED diag-
nostic problems during a 6-month period, there were
147,192 diagnoses in the mortality group and 63,862
diagnoses in the surviving group. The ICD-9-CM diag-
noses codes were categorized as described in Table 3.
Besides the primary cancer diagnosis, the 15 most com-
mon diagnoses for ED visits were ranked by frequency
and analyzed by the Chi-square test. The highly-ranked
diagnoses differed slightly between the two groups. The
first-ranked problem for visiting an ED in both groups
was related to symptoms, signs, and ill-defined condi-
tions (approximately 35%). Visits related to the digestive
system ranked second in both groups (18.5% - 19.0%).
However, the third-ranked problem among the cancer
survivors and decedents differed. The respiratory system
ranked third (12.3%) among the mortality group during
the last six months of life, while genitourinary problems
(11.2%) ranked third in the cancer survivors. Besides
symptoms, signs, and the primary cancer, the following
chief problems in the mortality group were observedTable 3 Distributions of ED utilization stratified by diagnostic
Summed disease categories of all ED utilizations
ICD_9 codes diagnostic category
001-139 Infectious and parasitic diseases
140-239 Neoplasms
240-279 Endocrine, nutritional and metabolic diseases and immunity d
280-289 Diseases of the blood and blood-forming organs
290-319 Mental disorders
320-389 Diseases of the nervous system and sense organs
390-459 Diseases of the circulatory system
460-519 Diseases of the respiratory system
520-579 Diseases of the digestive system
580-629 Diseases of the genitourinary system
680-709 Diseases of the skin and subcutaneous tissue
710-739 Diseases of the musculoskeletal system and connective tissue
740-759 Congenital abnormalities
760-779 Certain conditions originating in the perinatal period
780-799 Symptoms, signs, and ill-defined conditions
800-999 Injury and poisoningsignificantly less often than in the surviving group: geni-
tourinary system, circulatory system, nervous system,
mental disorders, musculoskeletal system and congenital
abnormalities.
Of all ED utilizations among all cancer patients, the
second top ranked problem was diseases of the digestive
system, but there was no statistically significant differ-
ence in ED utilization between the mortality group and
the survival group (19.0% v.s. 18.5%, p = 0.147). Among
the mortality group, patients with digestive problems
had a high number of ED visits during their last six
months of life in Taiwan.
Analyzing our cancer data, the prevalence of ED
utilization for cancer patients in Taiwan is illustrated in
Figure 2. The distributions of ED utilization in various
months in the two compared groups (mortality vs. sur-
vival groups) were obviously different in every three-
month period in 2008. Among the mortality group, a
higher prevalence of ED visits was found in the last 12-
month period. Furthermore, when the time was closer to
the end of life, ED visits became more frequent in the
cancer decedents. A Mantel-Haenszel extension of the
chi-square test for trend was significant (p < 0.001).
Discussion
Palliative care is an essential and fundamental compo-
nent of cancer care [22]. In end-of-life care, emergency
staffs (including physicians and nurses) are asked to re-
ceive hospice patients. ED staff need to recognize the














12.31 8.40 < 0.001
19.01 18.54 0.147
7.44 11.17 < 0.001
1.32 2.66 < 0.001
2.21 2.64 < 0.001
0.08 0.13 0.018
0.02 0.02 0.606
34.52 39.25 < 0.001
2.34 4.17 < 0.001
Figure 2 ED utilizations in the mortality and survival groups. A. Prevalence. B. Frequency of ED visiting times.
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dressed the suffering of EOL patients using a nationwide
dataset, and also described the visits of surviving pa-
tients with terminal cancer who presented to EDs [23].
Although palliative care is generally offered with the
standard services in various settings, systematic charac-
teristics influence the ability to implement the delivery
of care for terminally ill patients [24]. Based on this evi-
dence, an integrated community care service model
should be developed, which integrates palliative care
throughout the cancer trajectory [22].
Health system characteristics and patient cultural factors
may play roles in the observed differences [6]. Several stud-
ies in Western countries have emphasized that hospice care
at home is best for dying patients with cancer rather than
aggressive treatment. However, Taiwan health insurance
covers almost all medical services provided in hospitals for
cancer patients, and therefore there are fewer economic
barriers in end-of-life care. The barriers to ED utilization
are decreased for cancer patients owing to healthcare fee
remission. A study evaluating the medical utilization of the
Taiwan NHI system revealed that on average, a person had
13.4 physician consultations and visited 3.9 healthcare facil-
ities in a year, and 17.3% of the studied cohort had visiteddifferent healthcare facilities on the same day [25]. A co-
payment method was introduced into Taiwan’s healthcare
system, which could add some economic load and decrease
inappropriate use and overuse of medical resources. A
study analyzing the correlation between NHI-defined cata-
strophic illness and remitting medical expenditure revealed
that patients with any certificated catastrophic illness
tended to have significantly more ED visits and higher ED
costs due to untypical medical complaints [16]. Further-
more, cancer care could potentially tend to become aggres-
sive, as shown by the frequent ED visits and admissions to
intensive care units at patients’ end of life [5,13]. Advanced
care planning emphasizes value-based care and enables fur-
ther development towards hospice and palliative care [24].
The primary purpose of this study was to explore the
prevalence of ED utilization and the expenditure on emer-
gency care among the Taiwanese cancer population. A
greater emergency medical expenditure at the end of a
six-month period was observed in the mortality group,
which included treatment-associated expenditure and
drug-associated expenditure in Taiwan’s EDs. The average
costs were significantly higher in the mortality group than
in the survival group (US$7,442.4 vs. 4,243.6; p < 0.001).
The high utilization and medical costs were similar to those
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patients who died of cancer in 2001; 27.6% had at least one
ER visit and 5.4% had an ICU visit in the last two weeks of
life, and Barbera [15] indicated that the high proportion of
intensive therapies for cancer patients very near to death
represent poor-quality end-of-life care. Another similar re-
sult was also found in North Carolina in 2008: there were
194,017 ED visits by 76,759 patients with cancer, and
among these visits, those paying the most were with Medi-
care (for 52.4%) and Medicaid (for 12.1%). Hence, cancer
treatment costs are increasing at an unprecedented rate
[16,26]. The economics of health care need to be empha-
sized, and home-based palliative care needs to be consid-
ered in order to decrease the emergency expenditure and
number of visits at the end of life [27,28]. Palliative care is
one component of rural practice that requires interpro-
fessional collaboration. Members of the care team need
to have a sense of accountability and mutual respect.
Thereby the autonomic team of rural practitioner de-
vote their time to palliative care. That would be one of
potential reasons that access to care and service
utilization might be employed [29].
Age and gender effects were observed in end-of-life
ED utilization. In the present nationwide population
study, and some studies in the US and Canada, patients
were found to be more likely to receive aggressive cancer
care at the end of life if they were male, younger, lived in
rural regions, had a higher level of comorbidity, or had
breast, lung, or hematologic malignancies [6,30]. How-
ever, another study debated whether cancer-related ED
visits are more likely to be made by male patients and
those of an older age [31].
The results of Leak’s study also indicated that the chief
complaints among cancer ED visitors were in those
dying of respiratory and gastrointestinal symptoms and
those with a mental status change according to the
37,760 cancer-related ED visits contained in the North
Carolina Disease Event Tracking and Epidemiologic Col-
lection Tool [31]. The results were similar to the reason
distributions of the identified categories of patients with
cancer presented in the current study. Cardiopulmonary
arrest, respiratory distress, and shortness of breath are
well-known symptoms among end-of-life cancer patients
[32]; however, we need to be aware that abdominal pain
and gastrointestinal issues are also some of the most fre-
quent problems for cancer ED visits during the final six
months of life [16]. The results of Burge’s study in
Canada indicated that patients with a low continuity of
care made 3.9 more ED visits than those experiencing a
high continuity of care. The significant association be-
tween continuity of care and ED visits at the end of life
among cancer patients needs to be emphasized [28]. ED
visits can be prevented with appropriate home support
and education and a focus on symptom management[9,33], and keeping patients more comfortable at home
under palliative care indicates good-quality end-of-life
cancer care [12,34].
The strength of the present study was the nationwide
epidemiological survey to analyze the end-of-life care for
the Taiwanese cancer population. Some limitations exist:
if a patient suffered prolonged hospitalization in his or
her last 6 months of life, we may underestimate the ED
utilization. An additional limitation of claims data min-
ing is that there is a loss of detail. Possible confounders
were not controlled in the present study, including
socio-economic influences and family support, which
were unable to be extracted from the epidemiological
data. If patients do not have valid insurance, they may
die in distress. Further investigation using an integrated
community care model throughout the cancer trajectory
survey is recommended.Conclusion
Palliative care is an important issue for Taiwan cancer
patients and deserves more attention. Population-based
data can further provide evidence to support the devel-
opment of a cancer policy and EOL care services. Our
study provided population-based evidence of ED visits
by patients with cancer in Taiwan. The results also pro-
vided empirical evidence regarding what EOL cancer pa-
tients perceive as being their needs. Patients with
malignant cancer diagnoses had significantly more ED
visits and higher ED medical costs. An understanding of
the problems leading to such visits could be useful in
preventing the overuse of ED visits to improve the qual-
ity of EOL care.
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